Farcas Adriana, Christi Praise, Fagen Julia, Iftene Felicia
Center for Neuroscience Studies, Queen's University, Canada.
Faculty of Health Science, Queen's University, Canada.
Psychiatry Res Commun. 2022 Dec;2(4):100075. doi: 10.1016/j.psycom.2022.100075. Epub 2022 Sep 13.
The Covid-19 pandemic brought vaccination to the front of the series of measures implemented to address the chain-reaction outbreaks that continue to cause loss and suffering. In spite of its proven efficacy, a considerable percentage of the population remains hesitant or right-out opposed. A need for informing public health strategies not only in regards to the current pandemic but for future similar developments remains of utmost importance for researchers and clinicians alike, especially when it comes to vulnerable categories of population. Identifying risk factors associated with vaccine hesitancy in the psychiatric population is the aim of this scoping review.
We performed a systematic search on the topic of Covid-19 vaccine hesitancy in relation to psychiatric disorders, using three databases: Medline, PubMed and Embase. Inclusion criteria focused on studies looking at individuals with a psychiatric disorder in the context of the Covid-19 vaccine hesitancy where possible determinant factors were discussed.
Fifteen articles out of 219 publications on the topic of Covid 19 vaccine hesitancy met our inclusion criteria for this review. The common findings of these studies recognize the following risk factors for Covid 19 hesitancy: diagnosis of severe mental illness such as schizophrenia, lower socioeconomic status, lower educational level, and young age.
Our findings may contribute to the proactive development of educational strategies targeting the psychiatric population in the context of cultural, ethnic, age and gender diversity, in order to safeguard the wellbeing of all when facing pandemic events. Overarching future directions include creating vaccination promotion strategies specific for the psychiatric population.
新冠疫情使疫苗接种成为应对持续造成损失和痛苦的连锁反应疫情所采取的一系列措施的前沿举措。尽管疫苗已被证明有效，但仍有相当比例的人群对此犹豫不决甚至坚决反对。对于研究人员和临床医生而言，不仅要为当前疫情制定公共卫生策略，还要为未来类似情况制定策略，这一点至关重要，尤其是涉及弱势群体时。确定精神疾病患者中与疫苗犹豫相关的风险因素是本范围综述的目的。
我们使用三个数据库（Medline、PubMed和Embase）对与精神疾病相关的新冠疫苗犹豫主题进行了系统检索。纳入标准侧重于研究在新冠疫苗犹豫背景下患有精神疾病的个体，并讨论可能的决定因素。
在219篇关于新冠疫苗犹豫主题的出版物中，有15篇文章符合我们本次综述的纳入标准。这些研究的共同发现确认了以下与新冠疫苗犹豫相关的风险因素：精神分裂症等严重精神疾病的诊断、社会经济地位较低、教育水平较低以及年龄较小。
我们的研究结果可能有助于在文化、种族、年龄和性别多样性背景下，积极制定针对精神疾病患者群体的教育策略，以便在面对疫情时保障所有人的福祉。未来的总体方向包括制定针对精神疾病患者群体的疫苗推广策略。
